Legal & General Group 13F: Adds $3.6M to Alcon (ALC) Stake

Legal & General Group has increased its holdings in Alcon Inc. (NYSE:ALC), boosting its stake by 1.4% according to a recent 13F filing with the SEC. The group added 53,234 shares during the reporting period, bringing its total to approximately 3.95 million shares valued at $268.4 million.

What Changed in Legal & General Group's Alcon Inc. Position

Legal & General Group grew its position in Alcon Inc. by 1.4%, adding 53,234 shares to its portfolio. This brings its total holdings to 3,950,897 shares, valued at about $268.4 million as of the latest filing.

Other Institutional Activity in Alcon Inc.

Several other institutional investors have also adjusted their stakes in Alcon Inc. Bank of New York Mellon Corp increased its holdings by 2,478,144 shares, ending with 15,669,662 shares valued at approximately $1.18 billion, marking an 18.8% increase. Vanguard Capital Management LLC opened a new position with 14,871,607 shares worth around $1.12 billion. FMR LLC added 1,668,163 shares to its holdings, a 15.5% increase, resulting in 12,426,992 shares valued at $938.3 million. On the other hand, Aristotle Capital Management, LLC reduced its stake by 481,233 shares, a 4.3% decrease, leaving it with 10,584,374 shares worth about $796.2 million.

Alcon Inc. Stock Up 4.0%

Shares of NYSE:ALC traded near $67.93 on Thursday. Alcon Inc. has a market cap of approximately $31.8 billion and a P/E ratio of 39.0. The stock's 52-week range is between $61.84 and $92.55, with a 50-day moving average of $69.92 and a 200-day moving average of $76.05. The company maintains a current ratio of 2.20 and a debt-to-equity ratio of 23.77.

Recent Earnings

Alcon Inc. reported revenue of $10.63 billion, reflecting a growth rate of 9.4%. The company's net margin stands at 7.7% with a return on equity of 3.71%. Alcon's next earnings announcement is expected on August 10, 2026.

Dividend

Alcon Inc. offers an annual dividend rate of $0.36, yielding 0.56%, with a payout ratio of 20.39%.

Insider Buying and Selling at Alcon Inc.

Insider transactions at Alcon Inc. include several sales. On February 26, 2026, Sergio Duplan sold 15,000 shares at an average price of $86.54, and Laurent Attias sold 2,412 shares at $86.91. Earlier, on March 3, 2025, Duplan also sold 12,600 shares at $93.20, with part of the transaction planned under a Rule 10b5-1 plan.

Analysts Set New Price Targets

Analysts have recently set new price targets for Alcon Inc. On May 8, 2026, Barclays maintained a 'hold' rating with a target of $78. Wells Fargo and Mizuho both maintained 'buy' ratings with targets of $86 and $85, respectively, on May 7, 2026. The consensus among analysts is a 'buy' recommendation, with an average target price of $87.92 based on 15 opinions.

About Alcon Inc.

Alcon Inc., headquartered in Geneva, Switzerland, is a global eye care company involved in the research, development, and sale of eye care products. It operates through two main segments: Surgical and Vision Care. Alcon's offerings include surgical equipment, intraocular lenses, and vision care products, such as contact lenses and ocular health products. The company is led by CEO David J. Endicott and employs around 25,000 people worldwide.

Bottom Line

Legal & General Group's recent increase in its stake in Alcon Inc. highlights ongoing interest from institutional investors. While 13F filings provide a backward-looking view of institutional holdings, they offer valuable insights into investment trends. Investors often track these filings to gauge market sentiment and institutional confidence in a company's future prospects.